Analysts at Bank of America initiated coverage on Aduro BioTech Inc ADRO with a Buy rating. The target price for Aduro Biotech is set to $40. Aduro Biotech shares closed at $30.85 on Friday.
Analysts at Evercore Partners initiated coverage on Virtu Financial Inc VIRT with a Buy rating. The target price for Virtu Financial is set to $25. Virtu Financial shares closed at $22.30 on Friday.
Analysts at Oppenheimer initiated coverage on Godaddy Inc GDDY with a Outperform rating. The target price for Godaddy is set to $31. Godaddy shares closed at $24.88 on Friday.
RBC Capital initiated coverage on KemPharm Inc KMPH with a Outperform rating. The target price for KemPharm is set to $18. KemPharm shares closed at $12.05 on Friday.
Analysts at Deutsche Bank initiated coverage on Wix.Com Ltd WIX with a Hold rating. The target price for Wix.com is set to $25. Wix.com shares closed at $23.75 on Friday.
Deutsche Bank initiated coverage on Endurance International Group Hldgs Inc EIGI with a Hold rating. The target price for Endurance International Group is set to $19. Endurance International Group shares closed at $20.96 on Friday.
Analysts at Guggenheim Securities initiated coverage on Paratek Pharmaceuticals Inc PRTK with a Buy rating. The target price for Paratek Pharmaceuticals is set to $37. Paratek Pharmaceuticals' shares closed at $26.56 on Friday.
RBC Capital initiates coverage on Godaddy Inc GDDY with a Outperform rating. The target price for Godaddy is set to $30. Godaddy shares closed at $24.88 on Friday.
Analysts at Guggenheim Securities initiated coverage on Egalet Corp EGLT with a Buy rating. The target price for Egalet is set to $24. Egalet shares closed at $9.10 on Friday.
Wedbush initiated coverage on Cidara Therapeutics Inc CDTX with a Outperform rating. The target price for Cidara Therapeutics is set to $22. Cidara Therapeutics shares closed at $14.94 on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in